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Vitamin A is involved in regulation of glucose concentrations, lipid metabolism, and inflammation, which are major risk factors for
atherogenesis. However, the effect of vitaminA deficiency on atherogenesis has not been investigated.Therefore, the objective of the
current study was to examine whether vitamin A deficiency accelerates atherogenesis in apolipoprotein E-deficient mice (apoE−/−).
ApoE−/− mice were allocated into the following groups: control, fed vitamin A-containing chow diet; BC, fed chow diet fortified
with Dunaliella powder containing 𝛽c isomers; VAD, fed vitamin A-deficient diet; and VAD-BC group, fed vitamin A-deficient
diet fortified with a Dunaliella powder. Following 15 weeks of treatment, liver retinol concentration had decreased significantly
in the VAD group to about 30% that of control group. Vitamin A-deficient diet significantly increased both plasma cholesterol
concentrations and the atherosclerotic lesion area at the aortic sinus (+61%) compared to the control group. Dietary 𝛽c fortification
inhibited the elevation in plasma cholesterol and retarded atherogenesis in mice fed the vitamin A-deficient diet. The results imply
that dietary vitamin A deficiency should be examined as a risk factor for atherosclerosis and that dietary 𝛽c, as a sole source of
retinoids, can compensate for vitamin A deficiency.
1. Introduction
VitaminA is involved in regulation of glucose concentrations,
lipid metabolism, and inflammation, which are major risk
factors for atherosclerosis development [1]. All-trans retinoic
acid (RA), the endogenous ligand of the retinoic acid recep-
tors (RARs), inhibited experimental atherosclerosis [2, 3] and
increased the process of reverse cholesterol transport from
macrophages [4]. In previous studies, we demonstrated that
feed fortification with 𝛽-carotene, a vitamin A precursor, can
inhibit atherosclerosis in mouse models [5, 6]. Nonetheless,
the effect of dietary vitaminAdeficiency on atherogenesis has
not been studied.
The dietary sources of vitamin A are retinol and mainly
retinyl esters from animal origin or provitaminA carotenoids
from plant sources comprising numerous isomers of 𝛽-
carotene [7]. Vitamin A deficiency can lead to night blind-
ness, abnormal embryonic development, and various patho-
logical conditions [8]. The major cause of deficiency is low
dietary intake of vitamin A, common in developing countries
[9]. Several other conditions, such as inflammatory bowel
disease, recurrent pancreatitis, excessive alcohol consump-
tion, iron deficiency, and mutation in the 𝛽-carotene 15,15󸀠
monooxygenase 1 (BCMO1) gene can also cause vitamin A
deficiency [10–13].
Dietary vitamin A (retinol, retinyl esters, and provitamin
A carotenoids) is transported in chylomicrons to the liver
and extrahepatic tissues following intestinal absorption. It is
important to note that 66–75% of vitamin A is transported
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to the liver and stored in hepatic stellate cells (HSCs), while
25–33% is transported directly to various extrahepatic tissues
[14]. The liver secretes retinol bound to retinol-binding pro-
tein 4 (RBP4) in order to meet tissue needs [15]. In addition,
plasma all-trans RA can also contribute to tissue RA pools
[16]. Although retinol bound to RBP4 is the main source of
extrahepatic tissues, dietary vitamin A can compensate for
the absence of RBP4 in both mice and humans [17, 18].
The effect of dietary vitamin A deficiency on plasma lipid
profiles has been investigated. In one study, a vitamin A-
deficient diet decreased HDL cholesterol and had no effect
on non-HDL cholesterol or on triglyceride concentrations
in rats fed with this diet for three months [19], while in a
second study, a vitamin A-deficient diet decreased both HDL
cholesterol and triglycerides [20]. To our knowledge, there is
no data regarding the effect of a vitamin A-deficient diet in
animals challenged with a high-cholesterol high-fat diet or in
animal models for atherosclerosis.
A recent study demonstrated that BCMO1 deficiency
in mice prevents the conversion of 𝛽-carotene to retinoids
and leads to impaired lipid metabolism [21]. We previously
showed that a diet enriched in 9-cis-𝛽-carotene (9C𝛽C) pro-
vided as powder of the alga Dunaliella bardawil significantly
inhibits atherogenesis in a mouse model [6]. These findings
led us to examine whether a vitamin A-deficient diet may
accelerate atherogenesis and whether dietary carotenoids as
a sole source of vitamin A could compensate for dietary
vitamin A deficiency.
2. Materials and Methods
2.1. Mice. Male, 12-week-old apoE-deficient mice (apoE−/−)
(C57BL6 background, Jackson Laboratories) were used. Mice
were housed in plastic cages on a 12 h light/12 h dark cycle
with free access to feed and water. Mice were killed with
isoflurane. The Animal Care and Use Committee of Sheba
Medical Center, Tel-Hashomer, approved all animal protocols
(682/11).
2.2. Diet. Two commercial diets were used: a normal, low-fat
diet (18% protein, 5% fat; TD2018, Harlan Teklad) containing
15 IU/g vitamin A (4.5𝜇g retinol/g) and a vitamin A-deficient
diet (17.7% protein, 5% fat; TD86143, Harlan Teklad). We
used a powder of the alga Dunaliella bardawil (a gift from
Nikken Sohonsha, Japan) as a source for natural carotenoids.
The algal powder contains 6% 𝛽-carotene (weight/weight),
comprised of 50% all-trans and 50% 9-cis isomers [22]. To
prepare the feed, 0.25 L of distilled hot water was mixed
with 14 g of gelatin until the solution was clear. Then, 1 kg
of powdered feed and Dunaliella powder (80 g/kg feed) were
thoroughly mixed with the warm gelatin solution. After
solidifying, the feed was divided into tablets and stored in
the freezer. Feed was replaced every other day to minimize
oxidation and degradation of its ingredients.
2.3. Study Design
Experiment 1. Sixty-eight 12-week-old apoE−/− male mice
(weight 25 gr) were allocated into 4 groups, 17 animals per
group, according to their body weight, plasma cholesterol,
and triglyceride (TG) concentrations. The mice were fed for
15 weeks with the specified diet. The control group was fed
normal vitamin A-containing chow diet. The BC group was
fed chow diet fortified with the alga Dunaliella. The VAD
group was fed a vitamin A-deficient diet, and the VAD-BC
groupwas fed a vitaminA-deficient diet fortified with natural
carotenoids of the alga Dunaliella (80 g powder mixed with
1 kg feed). Mice were killed after 15 weeks.
Experiment 2. Fourteen 12-week-old apoE−/− male mice
(weight 25 gr) were allocated into two groups with seven
animals per group; the control group was fed chow diet and
the VAD group was fed a vitamin A-deficient diet. The mice
were fed for 15 weeks with the specified diet and were killed
after 15 weeks.
2.4. Lipid Analysis. We used a colorimetric enzymatic pro-
cedure to measure total plasma cholesterol (Chol, Roche/
Hitachi, Roche Diagnostics) and TG (triglyceride liquid,
Senitinel).
2.5. Carotenoid Analysis. BC isomer concentrations in the
plasma and in the liver were determined by HPLC according
to the method described by Shaish et al. [23].
2.6. Retinol Analysis. Retinol extraction from liver and
plasma was carried out the same way as 𝛽-carotene extrac-
tion. Briefly, samples (∼250mg liver and 200 𝜇L plasma) were
extracted with 2mL of ethanol containing 10 𝜇M butylated
hydroxytoluene. After the addition of 2mL of hexane and
1mL of DDW, the samples were mixed and centrifuged for
5min at 1000 g. The hexane layers of plasma samples were
dried under a stream of N
2
. The hexane layers of the liver
samples were saponified with 2% KOH in Absolute ETOH
for 30min at 50∘C. Then, by adding 2mL of saline and cen-
trifugation, the hexane layer was removed and dried under
a stream of N
2
. Dried samples were suspended in 200𝜇L
methanol, and retinol concentrations were determined by
reverse phase HPLC on a Vydac C18 column (201TP-54,
250 × 5mm, 5 𝜇m particle size; Vydac, Hesperia, CA) with
methanol/butanol/water 10mM ammonium acetate as the
mobile phase at a flow rate of 0.8mL/min. Retinol was
detected by monitoring its absorbance at 325 nm and by
comparison with the retention times of authentic standards.
Results are expressed as nanomoles of retinol per gram wet
weight of tissue.
2.7. Retinoic Acid Analysis. Concentrations of RAs were
determined in mouse plasma by our LC-MS method [24].
In summary, 100 𝜇L plasma was diluted with a threefold
volume of isopropanol, vortexed for 10 seconds, put in an
ultrasonic bath for 5 minutes, shaken for 6 minutes, and
centrifuged at 13,000 rpm in a Heraeus BIOFUGE Fresco at
+4∘C. After centrifugation, the supernatants were dried in
an Eppendorf concentrator 5301 (Eppendorf, Germany) at
30∘C. The dried extracts were resuspended with 60𝜇L of
methanol, vortexed, shaken, diluted with 40 𝜇L of 60mM
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aqueous ammonium acetate solution, transferred into the
autosampler, and subsequently analyzed.
2.8. Isolation of Primary Mouse Hepatic Stellate Cells. Mouse
livers were collected and washed three times in isotonic
saline.Then, HSCs were isolated using Pronase-Collagenase-
DNAse lysate followed by OptiPrep (Sigma-Aldrich) density
gradient centrifugation as described previously [25].
2.9. Glucose Tolerance Test. After 15 weeks, a glucose toler-
ance test (GTT) was performed onmice that were fasted for 4
hours. Mice were injected ip with 20%D-glucose, 1% of body
weight (v/w). Blood glucose concentrations were measured
periodically up to 120 minutes.
2.10. Assessment of Atherosclerosis in theAortic Sinus. Athero-
sclerotic fatty streak lesions were quantified by calculating the
lesion areas in the aortic sinus [26].
2.11. Fast Protein Liquid Chromatography Analysis of Lipopro-
teins. Plasma from 5 mice was pooled and serum lipopro-
teins were separated by size exclusion chromatography using
a Superose-6 column (30 cm) on fast protein liquid chro-
matography [27].
2.12. Analysis of Gene Expression by Real-Time PCR. A Nu-
cleospin RNA II kit (Macherey-Nagel) was used for RNA
extraction. A high capacity cDNA synthesis kit (Applied
Biosystems) was used to perform cDNA synthesis. Quan-
titative real-time PCR was performed with a 7900HT
PCR machine (Applied Biosystems), FastStart Universal
Probe Master ROX (Roche), and a FAM-labeled Taq-
Man primer and probe (Applied Biosystems and Roche)
for mouse Cyp7𝛼 (Mm00484152 mL, Applied Biosystems),
Ppar𝛾 (Mm01184322 mL, Applied Biosystems), Cyp26a1
(312454, Roche), and Hmgr (Mm01282499 mL, Applied
Biosystems). We used Gapdh (307884, Roche) as a reference
gene.
2.13. Statistical Analyses. One-way ANOVA was used to
compare the treatment effect on atherogenesis, with the post
hoc Tukey method used for multiple pairwise comparisons.
Repeated measures ANOVAwas applied to compare changes
in weight gain between the treatment groups over the study
period. Significance was considered as𝑃 < 0.05. Values in the
text are means ± SE. All statistics were conducted using SPSS
(release 12.0 SPSS Inc.).
3. Results
The aim of the study was to investigate whether a vitamin
A-deficient diet accelerates atherogenesis in apoE−/− mice
and to examine whether fortification of this diet with a
Dunaliella powder rich in 𝛽-carotene isomers, as a sole
source of dietary provitaminA,would compensate for dietary
vitamin A deficiency. We placed 68 apoE−/− male mice (Exp.
1) for 15 weeks on the following diet regimes: chow diet
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Figure 1: Mouse body weight throughout the study. Mice were
weighed every week (Exp. 1). A trend towards lower body weight
was noted in the VAD group (𝑃 = 0.072). Values are means ±
SE, 𝑛 = 15-16. Dunaliella treated group (BC); vitamin A-deficient
diet group (VAD); vitamin A-deficient diet fortified with Dunaliella
group (VAD-BC).
(control);Dunaliella powder-fortified diet, as a natural source
for 𝛽-carotene isomers (BC), vitamin A-deficient diet (VAD),
and vitamin A-deficient diet fortified withDunaliella powder
(VAD-BC). Vitamin A deficiency did not significantly affect
weight gain, although a trend towards lowerweight was noted
in the VAD group (𝑃 = 0.072), while weight gain in the BC-
fortified groups was similar to the control group (Figure 1).
3.1. Vitamin A-Deficient Diet Reduced Liver Retinol Content.
Similar to our previous mouse study [6], administration of
Dunaliella powder rich in 𝛽-carotene isomers resulted in
accumulation of both 9-cis and all-trans-𝛽-carotene isomers
in mouse livers. The concentrations of the two isomers were
2-3 times higher in the VAD-BC group compared to the
concentrations in the BC group, which also received vitamin
A in the form of retinyl ester in the feed (Figure 2(c)).
To study whether administration of a vitamin A-deficient
diet for 15 weeks led to the vitamin A deficiency in the
plasma and liver, we measured retinol concentrations by
HPLC in these tissues. Despite the long treatment time of
15 weeks, plasma retinol concentrations were similar in all
treatment groups, apparently due to homeostatic regulation
(Figure 2(a)). In contrast, liver total retinol concentrationwas
decreased significantly in the VAD group to about 30% that
of the control group, indicating that a substantial reservoir
of vitamin A still exists (Figure 2(b)). It is important to note
that fortification with Dunaliella powder rich in 𝛽-carotene
isomers did not restore liver retinol, and only a trend toward
higher concentrations was detected compared to the mice
treated with a vitamin A-deficient diet.
As most liver vitamin A is stored in hepatic stellate
cells, we measured retinol concentrations in isolated stellate
cells from control and VAD mice (Exp. 2). As expected,
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Figure 2: Plasma and liver retinol and 𝛽-carotene concentrations. Plasma retinol concentrations were similar in all groups (a), liver retinol
concentration decreased significantly in VAD group (b), liver𝛽c isomer concentrations were significantly higher in VAD-BC group compared
to BC group (c), and serum all-trans RA concentrations were similar in all groups (d). Retinol, 𝛽c, and RA were analyzed following 15 weeks
of treatments (Exp. 1). Values are means ± SE, 𝑛 = 5–8. a, bWithin each graph, means without a common letter differ, 𝑃 < 0.05. Dunaliella
treated group (BC); vitamin A-deficient diet group (VAD); vitamin A-deficient diet fortified with Dunaliella group (VAD-BC); retinoic acid
(RA).
a 50% decline in stellate cell retinol content was detected,
12.9 ng retinol per 106 HSC and 6.7 ng retinol per 106 HSC,
respectively.
RA in serum was detected by LC-MS. As RA is one
of the vitamin A active derivatives, we assumed that RA
concentration would change with respect to diets. In contrast
to our assumption that the VAD would reduce and the 𝛽-
carotene would increase serum all-trans RA concentrations,
all-trans RA concentrations were comparable in all examined
groups (Figure 2(d)).Moreover, despite the high dose of 9c𝛽C
in the diet, 9-cis RA was not detected in any of the four
groups.
3.2. Vitamin A-Deficient Diet Increased Plasma Cholesterol
Concentrations and Accelerated Atherosclerosis While Dietary
𝛽-Carotene Reversed These Effects. Vitamin A-deficient diet
significantly increased plasma cholesterol concentrations and
FPLC analysis showed that this increase is due to higher
concentrations of the atherogenic, non-HDL cholesterol.
Dietary 𝛽-carotene fortification suppressed this elevation,
and plasma cholesterol concentrations in the BC and VAD-
BC groups were lower throughout the experiments compared
to the control or the VAD group, respectively (Figure 3).
The atherosclerotic lesion area was quantified at the aortic
sinus by oil-red O staining of the lipids. The red color
indicates the presence of atherosclerotic lesions (Figure 5(b)).
The vitamin A-deficient diet significantly increased (61%) the
atherosclerotic lesion area at the aortic sinus compared to the
control group (Figure 4). Remarkably, although 𝛽-carotene
did not restore the liver retinol pool, it significantly inhibited
atherogenesis in mice fed a vitamin A-deficient diet, and the
lesion area was similar to the control group fed the vitamin
A-containing diet.
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Figure 3: Plasma cholesterol concentrations. Plasma cholesterol concentrations (a) and lipoprotein cholesterol content (b). Mice fed chow
or vitamin A-deficient diet with or without 𝛽C after 15 weeks of treatment. VAD significantly increased plasma cholesterol concentrations
due to increased levels of non-HDL cholesterol. Values are means ± SE, 𝑛 = 15-16. a, bWithin the graph, means without a common letter differ,
𝑃 < 0.05. Dunaliella treated group (BC); vitamin A-deficient diet group (VAD); vitamin A-deficient diet fortified with Dunaliella group
(VAD-BC).
3.3. Dietary Vitamin A Deficiency Did Not Induce Insulin
Resistance. As retinoids have been shown to impact glucose
metabolism, we assessed whether a vitamin A-deficient diet
affects glucose concentrations and insulin resistance in mice.
The GTT showed that a vitamin A-deficient diet did not
induce insulin resistance (data not shown).
3.4.The Effect of Vitamin A-Deficient Diet and BC Supplemen-
tation on Liver Gene Expression. In an effort to elucidate the
mechanisms of cholesterol elevation and accelerated athero-
genesis in VAD-treated mice, we measured the liver mRNA
levels of several genes related to retinoids and cholesterol
metabolism. Cyp26a1 regulates the cellular concentrations
of RA via oxidation and its expression levels are used as
a sensitive indicator for tissue RA concentration [28]. Its
lower mRNA levels in VAD-treated mice indicate lower RA
in the liver of VAD group. It is noteworthy that a diet rich
in Dunaliella powder rich in 𝛽-carotene isomers prevented
this decrease (Figure 5). Peroxisome proliferator-activated
receptor gamma (Ppar𝛾) participates in adipocyte differen-
tiation, glucose and insulin homeostasis, and inflammation,
and it was suggested that it plays an important role in several
diseases, including obesity, diabetes, and atherosclerosis [29].
ThemRNA levels of Ppar𝛾 decreased twofold in VAD-treated
mice compared to the control and increased slightly (not
significant) in the VAD-BC group.
Cholesterol-7-alpha-hydroxylase (Cyp7𝛼) catalyzes the
formation of 7-alpha-hydroxycholesterol, which is a rate-
limiting step in the synthesis of bile acids from cholesterol.
The rate-limited enzyme during cholesterol biosynthesis is 3-
hydroxy-3-methyl-glutaryl-CoA reductase (Hmgr). In VAD-
treated mice, Cyp7𝛼mRNA increased approximately twofold
and Hmgr decreased approximately threefold, probably as a
feedback reaction to the elevated plasma cholesterol concen-
trations. Supplementation of BC to vitamin A-deficient diet
significantly decreased Cyp7𝛼 mRNA levels possibly due to
lower plasma cholesterol concentrations, whileHmgrmRNA
levels were not affected.
4. Discussion
In this study, we showed that dietary vitamin A deficiency
significantly accelerates atherogenesis in an atherosclerosis
prone, apoE−/− mouse model, despite unaffected plasma
retinol and RA concentrations. We also found that a diet
enriched with 𝛽-carotene can compensate for the effects of
dietary vitamin A deficiency with regard to atherosclerosis
development.
Analyzing the hepatic retinol reservoir, as an indicator for
the available vitaminA in the animals, revealed a 30% hepatic
total retinol pool after 15 weeks of vitamin A-deficient diet
in comparison to mice fed a vitamin A-containing diet. This
reduction is lower than the drop reported in other mouse
strains fed with a vitamin A-deficient diet, SENCAR mice
[30], aryl hydrocarbon receptor- (AHR-) null mice [31], and
BALB/c mice [32]. The reason for the higher remaining pool
in apoE−/−mice is not known. As expected, decreased retinol
concentrations were also detected in stellate cells isolated
from the VAD group. As 𝛽-carotene is a source of vitamin
A in most diets, including human diets [33], and 𝛽-carotene
from Dunaliella was shown to be a precursor for retinol and
retinyl esters in rats [34], we assumed that fortification of
the vitamin A-deficient diet with 𝛽-carotene from Dunaliella
would restore liver retinoids. Interestingly, fortification of
the vitamin A-deficient diet with 𝛽-carotene isomers did not
completely restore liver retinol and only a trend towards
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Figure 4: Atherosclerotic lesion area in apoE−/− mice fed chow or vitamin A-deficient diet with or without 𝛽-carotene. The atherosclerotic
lesion area was quantified at the aortic sinus by oil-red O staining of the lipids after 15 weeks of treatment (a). One representative aortic sinus
lesion section is shown for each treatment group (magnification ×40). Red color indicates the presence of atherosclerotic lesions (b). The
vitamin A-deficient diet significantly increased the atherosclerotic lesion area while 𝛽-carotene reverts this effect. Values are means ± SE, 𝑛 =
13–15. a, bWithin the graph, means without a common letter differ, 𝑃 < 0.05. Dunaliella treated group (BC); vitamin A-deficient diet group
(VAD); vitamin A-deficient diet fortified with Dunaliella group (VAD-BC).
elevated total retinol concentrations was detected.Thus, liver
retinol pool was comparable in the VAD and VAD-BC
groups.We used Cyp26a1 to monitor liver RA concentrations
[28] and as expected, VAD group had significantly lower
mRNA levels of Cyp26a1, indicating lower levels of RA, and
BC reverts this effect. The lack of effect of the treatments
on plasma retinol or RA levels suggests dissociation between
their plasma levels and liver concentrations at these diet
regimes.
The two main isomers of 𝛽-carotene, all-trans and 9-
cis, were accumulated in the liver as in rats fed Dunaliella
bardawil powder [34] and in LDLR−/− mice [6]. Lack of
vitamin A in the diet caused significant hepatic elevation
in 9-cis and all-trans 𝛽-carotene concentrations after 𝛽-
carotene isomers supplementation compared to a vitamin
A-containing diet enriched with these isomers. This may
indicate that a lack of vitamin A in the diet and the ensuing
liver reservoir decline resulted in better absorption and/or
storage of 𝛽-carotene isomers. As retinoids are known to
regulate the expression of carotenoid transporters [35], the
higher concentrations of 𝛽-carotene isomers in the livers
of the VAD group may be a result of higher expression of
transporters involved in carotenoid absorption.
Plasma cholesterol concentrations were significantly
increased in mice that were fed the vitamin A-deficient
diet compared to the control group. These results contra-
dict previous findings by Gatica et al., which showed no
change in LDL and VLDL cholesterol concentrations in rats
fed a vitamin A-deficient diet [19]. Similarly, Oliveros et al.
demonstrated cholesterol and triglyceride concentration
decrement in rats fed a vitamin A-deficient diet [20]. It is
important to note that these experiments were conducted in
animal models with a normal lipid profile, whereas we, for
the first time, investigated the effects of vitamin A deficiency
in a hyperlipidemic, atherosclerosis prone mouse model. The
cholesterol elevation can be derived from increased synthesis,
increased cholesterol absorption, or reduced plasma choles-
terol clearance. In the analysis of Hmgr liver mRNA levels,
we found a significant decrease in the VAD group. It seems
that this decrease in liver Hmgr mRNA expression in the
vitamin A-deficient diet was due to a feedback inhibition
caused by the elevated plasma cholesterol concentrations in
this group. A similar mechanism may have caused elevation
in liver Cyp7𝛼 mRNA expression in the VAD group (the
first enzyme in the cholesterol-bile acid pathway), probably
in order to decrease cholesterol concentrations by turning
it into bile acids. These results suggest that the increased
concentrations of cholesterol are not due to increased choles-
terol synthesis in the liver or decreased bile acid synthesis
from cholesterol. The direct reason to the elevated plasma
cholesterol in the VAD group is not known. However, the
loss of retinol from HSC in the VAD group is an indi-
cation for stellate cell activation and development of liver
inflammation [36]. As liver inflammation is associated with
dyslipidemia [37] and has been suggested to contribute to
atherosclerosis [38], we assume that it also affects cholesterol
metabolism and contributed to atherogenesis in our mouse
model.
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Figure 5: Liver gene expression in apoE−/− mice fed chow or vitamin A-deficient diet with or without 𝛽-carotene. Liver mRNA levels of
the indicated genes were detected by real-time PCR. Gapdh was used as a reference gene. Gene expression was detected after 15 weeks of
treatment. Cyp26a1 (a), Ppar𝛾 (b), Cyp7𝛼 (c), andHmgr (d). Measured by real-time PCR and normalized to GAPDH. Values are means ± SE,
𝑛 = 8. a, b, cWithin each graph, means without a common letter differ, 𝑃 < 0.05. Dunaliella treated group (BC); vitamin A-deficient diet group
(VAD); vitamin A-deficient diet fortified with Dunaliella group (VAD-BC).
The results clearly show that dietary vitamin A deficiency
significantly increased the atherosclerotic lesion area, despite
the lack of effects on plasma concentrations of retinol and
all-trans RA. Studies on the effects of VAD on atherosclerosis
have not been published and the only study investigating the
effects on lipid accumulation in the blood vessels, by Gatica
et al., demonstrated that the concentrations of triglycerides
and total cholesterol increased in the aorta of rats treated
with a vitamin A-deficient diet [39].The results of the current
study are in accordance with previous studies from our
laboratory demonstrating that fortification of a diet contain-
ing vitamin A with the provitamin A carotenoids inhibits
atherosclerosis in apoE−/− and LDLR−/− mouse models
[5, 6].
It was unexpected to find that the remaining 30% liver
retinoids reservoir did not prevent the increment in plasma
cholesterol concentrations and accelerated atherogenesis and
that dietary 𝛽-carotene can inhibit the accelerated athero-
genesis without restoring the liver retinoid stockpile or
increasing plasma retinoid concentrations. D’Ambrosio et al.,
in their review on vitamin A metabolism [40], highlighted
the importance of postprandial retinyl ester uptake into
extrahepatic tissues and suggested that this pathway can
sufficiently provide tissue requirements. This opinion is
supported by findings showing that humans who lack retinol
binding protein (RBP4) [17] as well as RBP-deficient mice
[18] are physiologically normal (RBP4-deficient mice). We
suggest that dietary BC can supply vitamin A to peripheral
tissue directly, as intact BC molecule, or by its conversion to
retinyl ester in the intestine or in peripheral tissues expressing
BCMO1. In a recent study we showed that BCMO1 is
expressed and is active inmacrophages (accepted PLOS1) and
previous studies demonstrated its expression in adipocytes
[41]. Hence, delivery of BC and its conversion to retinoids
in BCMO1-expressing cells in peripheral tissues can poten-
tially retard atherosclerosis without restoring liver retinol
pools.
In summary, using an atherosclerotic mouse model, we
demonstrated that a diet low in vitamin A can be indicated
as a potential risk factor for atherosclerosis. Moreover, we
suggest that dietary carotenoids as a sole source for vitamin
A can compensate for vitamin A deficiency.
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